Annie Pierre Jonville-Bera

Summary

Country: France

Publications

  1. ncbi Sudden unexpected death in infants under 3 months of age and vaccination status- -a case-control study
    A P Jonville-Bera
    Department of Clinical Pharmacology and Regional Drug Monitoring Center University Hospital of Tours, France Unité Inserm U 149 Cochin Port Royal University Hospital, Paris, France
    Br J Clin Pharmacol 51:271-6. 2001
  2. ncbi Frequency of adverse drug reactions in children: a prospective study
    Annie Pierre Jonville-Bera
    Department of Clinical Pharmacology and Regional Drug Monitoring Centre, University Hospital of Tours, 2 Boulevard Tonellé, 37044 Tours Cedex, France
    Br J Clin Pharmacol 53:207-10. 2002
  3. ncbi Are incorrectly used drugs more frequently involved in adverse drug reactions? A prospective study
    A P Jonville-Bera
    Department of Clinical Pharmacology and Regional Drug Monitoring Centre, University Hospital, CHRU, 2 boulevard Tonnelle, 37044, Tours Cedex 09, France
    Eur J Clin Pharmacol 61:231-6. 2005
  4. ncbi Avoidability of adverse drug reactions spontaneously reported to a French regional drug monitoring centre
    Annie Pierre Jonville-Bera
    Pharmacoepidemiology and Clinical Pharmacology Unit Regional Drug Monitoring Centre, CHRU de Tours, Tours, France
    Drug Saf 32:429-40. 2009
  5. ncbi [Neonatal risks of drugs exposure at the end of pregnancy]
    Elisabeth Autret-Leca
    Centre Régional de Pharmacovigilance et d Information sur le Médicament, Tours, France
    Therapie 66:431-6. 2011
  6. ncbi Upper gastrointestinal complications associated with NSAIDs in children
    Elisabeth Autret-Leca
    CHRU of Tours, Regional Centre of Pharmacovigilance, Department of Pharmacology, Hopital Bretonneau, 2 boulevard Tonnelle, 37044 Tours cedex 9, France
    Therapie 62:173-6. 2007
  7. ncbi Drug dependence associated with triptans and ergot derivatives: a case/non-case study
    Frédérique Beau-Salinas
    Department of Pharmacology, CHRU of Tours, Bretonneau Hospital, Regional Centre of Pharmacovigilance, France
    Eur J Clin Pharmacol 66:413-7. 2010
  8. ncbi [Hydroxychloroquine during pregnancy: a review of retinal toxicity in the newborns]
    Naoual Tarfaoui
    Centre Régional de Pharmacovigilance et d Information sur le Médicament, Service de Pharmacologie Clinique, Tours, France
    Therapie 68:43-7. 2013
  9. ncbi Heptavalent pneumococcal conjugate vaccine (PCV7): French survey of serious adverse reactions
    Elisabeth Autret-Leca
    Centre Régional de Pharmacovigilance et d Information sur le Médicament, Tours, France
    Therapie 66:81-6. 2011
  10. ncbi Drug exposure during the periconceptional period: a study of 1793 women
    Elisabeth Autret-Leca
    CHRU de Tours, Service de Pharmacologie Clinique, Centre Rgional de Pharmacovigilance et dInformation sur le Mdicament, Tours, France
    Paediatr Drugs 13:317-24. 2011

Collaborators

Detail Information

Publications17

  1. ncbi Sudden unexpected death in infants under 3 months of age and vaccination status- -a case-control study
    A P Jonville-Bera
    Department of Clinical Pharmacology and Regional Drug Monitoring Center University Hospital of Tours, France Unité Inserm U 149 Cochin Port Royal University Hospital, Paris, France
    Br J Clin Pharmacol 51:271-6. 2001
    ..To determine whether DTPP+Hib vaccination (diphtheria, tetanus, pertussis, poliomyelitis +/- haemophilus) increased the risk of sudden unexpected death (SUD) in children under 3 months of age...
  2. ncbi Frequency of adverse drug reactions in children: a prospective study
    Annie Pierre Jonville-Bera
    Department of Clinical Pharmacology and Regional Drug Monitoring Centre, University Hospital of Tours, 2 Boulevard Tonellé, 37044 Tours Cedex, France
    Br J Clin Pharmacol 53:207-10. 2002
    ..To assess the frequency of adverse drug reactions (ADRs) in children in France...
  3. ncbi Are incorrectly used drugs more frequently involved in adverse drug reactions? A prospective study
    A P Jonville-Bera
    Department of Clinical Pharmacology and Regional Drug Monitoring Centre, University Hospital, CHRU, 2 boulevard Tonnelle, 37044, Tours Cedex 09, France
    Eur J Clin Pharmacol 61:231-6. 2005
    ....
  4. ncbi Avoidability of adverse drug reactions spontaneously reported to a French regional drug monitoring centre
    Annie Pierre Jonville-Bera
    Pharmacoepidemiology and Clinical Pharmacology Unit Regional Drug Monitoring Centre, CHRU de Tours, Tours, France
    Drug Saf 32:429-40. 2009
    ..Adverse drug reactions (ADRs) are now recognized as a major category of iatrogenic illness in terms of morbidity and mortality...
  5. ncbi [Neonatal risks of drugs exposure at the end of pregnancy]
    Elisabeth Autret-Leca
    Centre Régional de Pharmacovigilance et d Information sur le Médicament, Tours, France
    Therapie 66:431-6. 2011
    ....
  6. ncbi Upper gastrointestinal complications associated with NSAIDs in children
    Elisabeth Autret-Leca
    CHRU of Tours, Regional Centre of Pharmacovigilance, Department of Pharmacology, Hopital Bretonneau, 2 boulevard Tonnelle, 37044 Tours cedex 9, France
    Therapie 62:173-6. 2007
    ..To analyse serious upper gastrointestinal (UGI) complications associated with non-salicylate non-steroidal anti-inflammatory drugs (NSAIDs) in children...
  7. ncbi Drug dependence associated with triptans and ergot derivatives: a case/non-case study
    Frédérique Beau-Salinas
    Department of Pharmacology, CHRU of Tours, Bretonneau Hospital, Regional Centre of Pharmacovigilance, France
    Eur J Clin Pharmacol 66:413-7. 2010
    ..The aim of this case/non-case study was to assess and compare the risk of drug dependence associated with different migraine-specific drugs, i.e., ergot derivatives and triptans, using the French pharmacovigilance database...
  8. ncbi [Hydroxychloroquine during pregnancy: a review of retinal toxicity in the newborns]
    Naoual Tarfaoui
    Centre Régional de Pharmacovigilance et d Information sur le Médicament, Service de Pharmacologie Clinique, Tours, France
    Therapie 68:43-7. 2013
    ..The objective of this study is to review the published data on ocular toxicity in newborns after in utero exposure to hydroxychloroquine...
  9. ncbi Heptavalent pneumococcal conjugate vaccine (PCV7): French survey of serious adverse reactions
    Elisabeth Autret-Leca
    Centre Régional de Pharmacovigilance et d Information sur le Médicament, Tours, France
    Therapie 66:81-6. 2011
    ..Previous study did not reveal any particular heptavalent pneumococcal conjugate vaccine (PCV7) related risk. However, french drugs agency (Afssaps) requested the continuation of its surveillance...
  10. ncbi Drug exposure during the periconceptional period: a study of 1793 women
    Elisabeth Autret-Leca
    CHRU de Tours, Service de Pharmacologie Clinique, Centre Rgional de Pharmacovigilance et dInformation sur le Mdicament, Tours, France
    Paediatr Drugs 13:317-24. 2011
    ..Many studies have described the prescribing of drugs to pregnant women, but only very few have data concerning the periconceptional period specifically...
  11. ncbi Isotretinoin exposure during pregnancy: assessment of spontaneous reports in France
    Elisabeth Autret-Leca
    CHRU de Tours, Service de Pharmacologie Clinique, Centre Régional de Pharmacovigilance et d Information sur le Médicament, Tours, France
    Drug Saf 33:659-65. 2010
    ..The relaxation of these recommendations (summary of product characteristics 2004), combined with the release of generic brands, encouraged us to carry out a fourth study...
  12. ncbi Amoxicillin/clavulanic acid is ineffective at preventing otitis media in children with presumed viral upper respiratory infection: a randomized, double-blind equivalence, placebo-controlled trial
    Elisabeth Autret-Leca
    Department of Clinical Pharmacology, Hospital Bretonneau and University François Rabelais, Tours, France
    Br J Clin Pharmacol 54:652-6. 2002
    ..To assess the equivalence of amoxicillin/clavulanic acid and placebo in the prevention of acute otitis media in children at high risk of acute otitis media who develop upper respiratory tract infection...
  13. ncbi A prescription and administration error of cisplatin: a case report
    Xavier Pourrat
    Pharmacy Department, University Hospital of Tours, 2 boulevard Tonnell, 37044 Tours Cedex, France
    Pharm World Sci 26:64-5. 2004
    ..The medication error was identified as wrong prescription copying by a junior prescriber and the prescription was validated by mistake by the pharmacist in charge of dispensing...
  14. ncbi Clinical features and risk factors for upper gastrointestinal bleeding in children: a case-crossover study
    Lamiae Grimaldi-Bensouda
    Inserm U657 Pharmacoepidemiology Unit, Paris, France
    Eur J Clin Pharmacol 66:831-7. 2010
    ....
  15. ncbi A case of severe toxicity during coadministration of vincristine and piperacillin: are drug transporters involved in vincristine hypersensitivity and drug-drug interactions?
    Chantal Le Guellec
    Department of Pharmacology, Faculte de Medecine, Universite Francois Rabelais, Tours, France
    J Pediatr Hematol Oncol 34:e341-3. 2012
    ..The patient was heterozygous for several common polymorphisms of ABCC2 (multidrug-related protein-2), CYP3A5, and ABCB1 (multidrug-related protein-1, P-glycoprotein), but their role in the toxicity cannot be ascertained...
  16. ncbi A multicentre case-control study of nonsteroidal anti-inflammatory drugs as a risk factor for severe sepsis and septic shock
    Annick Legras
    Department of Intensive Care Unit, University Hospital of Tours, boulevard Tonnelle, 37044 Tours, France
    Crit Care 13:R43. 2009
    ..We aimed to establish whether the use of nonsteroidal anti-inflammatory drugs (NSAIDs) during evolving bacterial community-acquired infection in adults is associated with severe sepsis or septic shock...
  17. ncbi [Adverse drug reactions of strontium ranelate(Protelos(®) in France]
    Annie Pierre Jonville-Bera
    CHRU de Tours, Service de Pharmacologie Clinique, Centre Régional de Pharmacovigilance et d Information sur le Médicament, 37044 Tours, France
    Presse Med 40:e453-62. 2011
    ..Study of side effects (SE) associated with strontium ranelate required by the French Drug agency (Afssaps)...